The Complete Clinical Research Auditing Solution
Dedicated to compliance consultancy of your Clinical Research and Post Marketing needs.
Start Your Clinical AuditA passion for Clinical Research Auditing
A comprehensive suite of professional services catering to a diverse clientele, from startup biotech to established multinationals — with a focus on quality, compliance, and inspection readiness.
Risk Management
Risk analysis and planning, risk management and remediation, corrective and preventative action (CAPA), and proactive risk mitigation strategies.
Auditing
Pharmacovigilance (clinical trial and post-marketing), supplier, investigator site, data (clinical study reports, statistics, CTD) and system audits.
Inspection Planning and Management
Comprehensive inspection preparation including mock inspections, sponsor oversight support, and ongoing inspection management.
Consulting
Quality Management System (QMS) development including controlled documents, SOPs, and full electronic QMS design and implementation.
Training
GxP training programmes, inspection preparation training, CAPA management training, and bespoke workshops for clinical teams.
For Cause
Expert management of for cause investigations, root cause analysis, regulatory response support, and CAPA implementation.
“360 CRC has saved us hours of work and has unlocked insights we never thought possible.”
Annie Steiner
CEO, Greenprint
Our Commitment to Quality
At 360 Clinical Research Consultancy, quality is not a checkbox — it is the foundation of everything we do. 360 CRC brings deep clinical research expertise and regulatory knowledge to every engagement, helping organisations achieve lasting compliance and inspection confidence.
Start Your Clinical AuditReady to strengthen your compliance?
Talk to 360 CRC today about how 360 Clinical Research Consultancy can help your organisation achieve and maintain regulatory compliance.
Get in TouchLatest Posts
5 min read
A sponsor company running a suite of early access programs discovered critical gaps in oversight, safety reporting, and HCP accountability — prompting a structured audit-led intervention.
30 Aug 2025
Read More →
12 min read
A start-up biotech company developing an innovative investigational drug product faced growing challenges around oversight, data integrity, and inspection readiness as it moved into later phase development.
24 Apr 2025
Read More →